Skip to main content

Bicuspid aortic valve with Severe AR

 


Bicuspid Aortic Valve (BAV) can cause severe aortic regurgitation (AR) through several mechanisms:


Congenital Abnormalities

1. Abnormal valve morphology: BAVs often have an abnormal valve morphology, which can lead to incomplete closure of the valve leaflets, resulting in AR.

2. Fusion of valve leaflets: In BAV, the valve leaflets may be fused together, creating a single, abnormal leaflet that cannot close properly, leading to AR.


Acquired Changes

1. Valve calcification: Over time, BAVs can become calcified, leading to stiffening of the valve leaflets and incomplete closure, resulting in AR.

2. Valve prolapse: BAVs can also prolapse, causing the valve leaflets to bulge backward into the left ventricle, leading to AR.


Aortic Root Changes

1. Aortic root dilation: BAVs are often associated with aortic root dilation, which can lead to AR by causing the valve leaflets to become misaligned.

2. Aortic aneurysm formation: In some cases, BAVs can lead

[3/4, 1:39 PM] Meta AI: Bicuspid Aortic Valve (BAV) can cause severe aortic regurgitation (AR) through several mechanisms:


Congenital Abnormalities

1. Abnormal valve morphology: BAVs often have an abnormal valve morphology, which can lead to incomplete closure of the valve leaflets, resulting in AR.

2. Fusion of valve leaflets: In BAV, the valve leaflets may be fused together, creating a single, abnormal leaflet that cannot close properly, leading to AR.


Acquired Changes

1. Valve calcification: Over time, BAVs can become calcified, leading to stiffening of the valve leaflets and incomplete closure, resulting in AR.

2. Valve prolapse: BAVs can also prolapse, causing the valve leaflets to bulge backward into the left ventricle, leading to AR.


Aortic Root Changes

1. Aortic root dilation: BAVs are often associated with aortic root dilation, which can lead to AR by causing the valve leaflets to become misaligned.

2. Aortic aneurysm formation: In some cases, BAVs can lead to the formation of an aortic aneurysm, which can cause AR by stretching the valve leaflets apart.


Other Factors

1. Genetic predisposition: Some individuals with BAV may have a genetic predisposition to develop AR.

2. Hemodynamic changes: Changes in blood flow and pressure can also contribute to the development of AR in individuals with BAV.


These mechanisms can contribute to the development of severe AR in individuals with BAV, highlighting the importance of regular monitoring and timely intervention.

Comments

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...